Project Pipeline

Oasmia’s pipeline of development programs includes Cantrixil, in clinical development for late-stage ovarian cancer, and Docetaxel micellar, in development for advanced prostate cancer.

1Indication and product name may differ between regions.

Cantrixil Global
Docetaxel micellar EU/EEA